M&A Deal Summary |
|
---|---|
Date | 2023-01-08 |
Target | Amryt Pharma |
Sector | Life Science |
Buyer(s) | Chiesi Farmaceutici |
Deal Type | Add-on Acquisition |
Deal Value | 1.5B USD |
Advisor(s) | Moelis & Co. (Financial) Cooley Gibson, Dunn & Crutcher (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Chiesi Farmaceutici is a research-focused international group, with more than 75 years of experience headquartered in Parma (Italy). Chiesi researches, develops and commercializes innovative pharmaceutical solutions in the respiratory therapeutics and specialist medicine areas.
DEAL STATS | # |
---|---|
Overall | 5 of 5 |
Sector (Life Science) | 4 of 4 |
Type (Add-on Acquisition) | 3 of 3 |
Country (Ireland) | 1 of 1 |
Year (2023) | 1 of 1 |
Size (of disclosed) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-05-23 |
Raptor Pharmaceuticals
Novato, California, United States Raptor Pharmaceutical Corp. is a bio pharmaceutical company focused on the development and commercialization of transformative therapeutics for rare, debilitating and often fatal diseases. Raptor Pharmaceuticals Corp. was established in 2005 and is headquartered in Novato, California. |
Buy | $70M |